Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1988 3
1989 1
1990 1
1991 2
1992 1
1995 1
1997 1
1998 2
1999 1
2000 1
2001 3
2002 3
2003 1
2004 2
2005 1
2007 1
2008 1
2009 7
2010 10
2011 5
2012 8
2013 6
2014 5
2015 4
2016 9
2017 6
2018 11
2019 13
2020 17
2021 20
2022 22
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. N Engl J Med. 2021. PMID: 32678530 Free PMC article. Clinical Trial.
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, Panagaki A, Melachroinopoulos N, Drakou E, Marousis K, Chrysos G, Spyrou A, Alexiou N, Symbardi S, Alexiou Z, Lagou S, Kolonia V, Gkavogianni T, Kyprianou M, Anagnostopoulos I, Poulakou G, Lada M, Makina A, Roulia E, Koupetori M, Apostolopoulos V, Petrou D, Nitsotolis T, Antoniadou A, Giamarellos-Bourboulis EJ. Kyriazopoulou E, et al. Am J Respir Crit Care Med. 2021 Jan 15;203(2):202-210. doi: 10.1164/rccm.202004-1201OC. Am J Respir Crit Care Med. 2021. PMID: 32757963 Free PMC article. Clinical Trial.
Thiazole Ring-A Biologically Active Scaffold.
Petrou A, Fesatidou M, Geronikaki A. Petrou A, et al. Molecules. 2021 May 25;26(11):3166. doi: 10.3390/molecules26113166. Molecules. 2021. PMID: 34070661 Free PMC article. Review.
Its derivatives have a wide range of biological activities such as antioxidant, analgesic, and antimicrobial including antibacterial, antifungal, antimalarial, anticancer, antiallergic, antihypertensive, anti-inflammatory, and antipsychotic. Indeed, the thiazole scaffold i …
Its derivatives have a wide range of biological activities such as antioxidant, analgesic, and antimicrobial including antibacterial, antifu …
Heterocycle Compounds with Antimicrobial Activity.
Fesatidou M, Petrou A, Athina G. Fesatidou M, et al. Curr Pharm Des. 2020;26(8):867-904. doi: 10.2174/1381612826666200206093815. Curr Pharm Des. 2020. PMID: 32026773 Review.
Rituximab-induced late-onset neutropenia.
Sahu KK, Petrou N, Cohn Z, Khanna S. Sahu KK, et al. BMJ Case Rep. 2019 Dec 29;12(12):e233569. doi: 10.1136/bcr-2019-233569. BMJ Case Rep. 2019. PMID: 31888912 Free PMC article. No abstract available.
Effect of Protocolized Weaning With Early Extubation to Noninvasive Ventilation vs Invasive Weaning on Time to Liberation From Mechanical Ventilation Among Patients With Respiratory Failure: The Breathe Randomized Clinical Trial.
Perkins GD, Mistry D, Gates S, Gao F, Snelson C, Hart N, Camporota L, Varley J, Carle C, Paramasivam E, Hoddell B, McAuley DF, Walsh TS, Blackwood B, Rose L, Lamb SE, Petrou S, Young D, Lall R; Breathe Collaborators. Perkins GD, et al. JAMA. 2018 Nov 13;320(18):1881-1888. doi: 10.1001/jama.2018.13763. JAMA. 2018. PMID: 30347090 Free PMC article. Clinical Trial.
New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5H)ones as Possible Anti-Inflammatory Agents.
Tratrat C, Haroun M, Paparisva A, Kamoutsis C, Petrou A, Gavalas A, Eleftheriou P, Geronikaki A, Venugopala KN, Kochkar H, Nair AB. Tratrat C, et al. Molecules. 2021 Jan 27;26(3):659. doi: 10.3390/molecules26030659. Molecules. 2021. PMID: 33513963 Free PMC article.
METHODS: Prediction of the anti-inflammatory action of the compounds was performed using PASS Program. The anti-inflammatory activity was evaluated by the carrageenan paw edema test. ...
METHODS: Prediction of the anti-inflammatory action of the compounds was performed using PASS Program. The anti-inflammatory a …
Enhancement of the Anti-Inflammatory Activity of NSAIDs by Their Conjugation with 3,4,5-Trimethoxybenzyl Alcohol.
Tziona P, Theodosis-Nobelos P, Papagiouvannis G, Petrou A, Drouza C, Rekka EA. Tziona P, et al. Molecules. 2022 Mar 24;27(7):2104. doi: 10.3390/molecules27072104. Molecules. 2022. PMID: 35408503 Free PMC article.
The activity of the novel derivatives was examined in vivo on carrageenan-induced inflammation, and in vitro, as cyclooxygenase and lipoxygenase inhibitors. It was found that the new compounds were more potent anti-inflammatory agents than the parent drugs. Thus, the ibupr …
The activity of the novel derivatives was examined in vivo on carrageenan-induced inflammation, and in vitro, as cyclooxygenase and lipoxyge …
Protocolised non-invasive compared with invasive weaning from mechanical ventilation for adults in intensive care: the Breathe RCT.
Perkins GD, Mistry D, Lall R, Gao-Smith F, Snelson C, Hart N, Camporota L, Varley J, Carle C, Paramasivam E, Hoddell B, de Paeztron A, Dosanjh S, Sampson J, Blair L, Couper K, McAuley D, Young JD, Walsh T, Blackwood B, Rose L, Lamb SE, Dritsaki M, Maredza M, Khan I, Petrou S, Gates S. Perkins GD, et al. Health Technol Assess. 2019 Sep;23(48):1-114. doi: 10.3310/hta23480. Health Technol Assess. 2019. PMID: 31532358 Free PMC article. Clinical Trial.
Methods for Estimating Long-Term Outcomes for Trastuzumab Deruxtecan in HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies.
Dunton K, Vondeling G, Hancock E, Petrou M, Burn O, Paine A. Dunton K, et al. Target Oncol. 2022 Nov;17(6):655-663. doi: 10.1007/s11523-022-00923-9. Epub 2022 Nov 7. Target Oncol. 2022. PMID: 36342619 Free PMC article. Clinical Trial.
BACKGROUND: DESTINY-Breast01 (NCT03248492) is a phase II single-arm trial evaluating trastuzumab deruxtecan (T-DXd) in adults with human epidermal growth factor receptor 2-positive (HER2+) unresectable or metastatic breast cancer (u/mBC) who have received two or more prior ant …
BACKGROUND: DESTINY-Breast01 (NCT03248492) is a phase II single-arm trial evaluating trastuzumab deruxtecan (T-DXd) in adults with human epi …
164 results